John P. Schmid Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

XERS Quotes by TradingView

John P. Schmid is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 113,159 shares of XERS, which is worth approximately $305,529. The most recent transaction as insider was on Jun 05, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K
79.17% 3M change
79.17% 12M change
Total Value Held $305,529

John P. Schmid Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 30.64%
113,159 Common Stock
Jun 07 2023
BUY
Grant, award, or other acquisition
-
42,500 Added 40.22%
63,159 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 42.07%
20,659 Common Stock
Oct 05 2021
BUY
Grant, award, or other acquisition
-
5,659 Added 50.0%
5,659 Common Stock

Also insider at

ANAB
ANAPTYSBIO, INC Healthcare
DSGN
Design Therapeutics, Inc. Healthcare
XERS
XERIS PHARMACEUTICALS INC Healthcare
Director
PSTX
Poseida Therapeutics, Inc. Healthcare
JPS

John P. Schmid

Director
Carlsbad, CA

Track Institutional and Insider Activities on XERS

Follow Xeris Biopharma Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XERS shares.

Notify only if

Insider Trading

Get notified when an Xeris Biopharma Holdings, Inc. insider buys or sells XERS shares.

Notify only if

News

Receive news related to Xeris Biopharma Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XERS